Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
이 보고서는 중동 및 북아프리카의 임상시험 인프라 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 주요 국가별 상세 분석, 경쟁 구도 등을 정리했습니다.
목차
제1장 주요 요약
- 시장 전망
- 조사 범위
- 이 조사를 실시하는 이유
- 시장 요약
제2장 중동 및 북아프리카의 임상시험 산업의 전망
- 세계의 임상시험 시장 : 개요
- 중동 및 북아프리카의 점유율
- 진화하는 중동 및 북아프리카의 임상시험 업계
- 인프라 및 리소스 : 신흥 시장의 격차 해소
- 환자 모집 잠재력 : 다양한 환자층과 높은 모집률
- 비용 효율성
- 규제 환경 : 조화와 지역 적응
- 정부의 지원과 투자
- 지역 정책의 영향 : 임상연구의 장려
- 협업으로 지역 네트워크 확대
- 새로운 동향 : 정밀의료와 희귀질환에 초점
- 종양학 및 희귀 질환에서 수요 증가
- 기술의 진보 : 임상 운영의 디지털화
- 중동 및 북아프리카의 임상시험 환경 이해
제3장 시장 역학
- 시장 역학
- 시장 성장 촉진요인
- 임상시험 타당성을 주도하는 규제 프레임워크
- 환자 모집과 다양성을 향상시키는 환자 인구 증가
- 기술의 진보에 의한 업무의 효율화
- 협업
- 맞춤형 의료의 시험 설계
- 시장의 과제
- 복잡한 규제 상황
- 환자 모집과 유지의 한계
- 불충분한 인프라와 현장 수용력
- 디지털 기술 도입 제한
- 주요 치료 영역을 둘러싼 경쟁
- 시장 기회
- 규제 개혁에 의해 승인의 신속화가 가능
- 종양학과 희귀 질환에 대한 새로운 주목
- 관민 연계에 의한 연구 능력의 강화
- 정밀의료 및 유전체학에 초점
제4장 시장 세분화 분석
- 세분화의 내역
- 시장 분석 : 스폰서 유형별
- 시장 분석 : 상유형별
- 시장 분석 : 서비스 유형별
- 시장 분석 : 연구 유형별
- 시장 분석 : 치료 영역별
제5장 신흥 시장
- 이집트
- 개요
- 임상시험의 정세분석
- 관찰
- BCC에 의한 추천 사항
- 사우디아라비아(KSA)
- 개요
- 임상시험의 정세분석
- 관찰
- BCC에 의한 추천 사항
- 레바논
- 개요
- 임상시험의 정세분석
- 관찰
- BCC에 의한 추천 사항
- UAE
- 개요
- 임상시험의 정세분석
- 관찰
- BCC에 의한 추천 사항
- 이란
- 개요
- 임상시험의 정세분석
- 관찰
- BCC에 의한 추천 사항
제6장 러시아·우크라이나 전쟁의 영향 분석
- 개요
- 공급망의 혼란
- 규제상의 과제
- 환자의 모집과 유지
- 지정학적 리스크
제7장 경쟁 구도
- 개요
- 경쟁 구도
- 국제 CRO와 제약 회사
- 현지 CRO 및 기관
- 학술연구기관
- 임상시험제품과 서비스 매핑
- 중동 및 북아프리카에서의 최근 임상시험 최근 동향
- BCC에 의한 총론
제8장 부록
KTH
This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.
Report Scope
This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.
This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA's emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.
Report Includes
- Analysis of the Middle East and Northern Africa's (MENA) regional markets for clinical trial infrastructure
- Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029
- Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country
- An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets
- Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects
- Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention
- Analysis of the industry structure, including stakeholders' market shares, clinical trial product/services mapping, and recent key developments
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Reasons for Doing this Study
- Market Summary
Chapter 2 MENA Clinical Trial Industry Outlook
- Global Clinical Trial Market Overview
- MENA Share
- Evolving MENA Clinical Trial Industry
- Infrastructure and Resources: Bridging Gaps in Emerging Markets
- Patient Recruitment Potential: Diverse Populations and High Recruitment Rates
- Cost-Effectiveness
- Regulatory Environment: Harmonization and Local Adaptations
- Government Support and Investments
- Impact of Regional Policies: Incentivizing Clinical Research
- Collaborations Expand Regional Networks
- Emerging Trends: Focus on Precision Medicine and Rare Diseases
- Growing Demand in Oncology and Rare Diseases
- Technological Advances: Digitalizing Clinical Operations
- Understanding the MENA Clinical Trial Landscape
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Regulatory Frameworks Driving Trial Feasibility
- Growing Patient Population Enhancing Recruitment and Diversity
- Technological Advances Streamlining Operations
- Collaborations
- Personalized Medicine Shaping Trial Design
- Market Challenges
- Complex Regulatory Landscape
- Limited Patient Recruitment and Retention
- Insufficient Infrastructure and Site Capacity
- Limited Adoption of Digital Technologies
- Competition for Key Therapeutic Areas
- Market Opportunities
- Regulatory Reforms Enabling Faster Approvals
- Emerging Focus on Oncology and Rare Diseases
- Public-Private Partnerships Boosting Research Capacity
- Focus on Precision Medicine and Genomics
Chapter 4 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis, by Sponsor Type
- Market Analysis, by Phase
- Market Analysis, by Service Type
- Market Analysis, by Study Type
- Market Analysis, by Therapeutic Area
Chapter 5 Emerging Markets
- Egypt
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- Kingdom of Saudi Arabia (KSA)
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- Lebanon
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- United Arab Emirates
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
- Iran
- Overview
- Clinical Trial Landscape Analysis
- Observations
- BCC Recommendations
Chapter 6 Russia-Ukraine War Impact Analysis
- Overview
- Supply Chain Disruptions
- Regulatory Challenges
- Patient Recruitment and Retention
- Geopolitical Risks
Chapter 7 Competitive Landscape
- Overview
- Competitive Landscape
- International CROs and Pharmaceutical Companies
- Local CROs and Institutions
- Academic and Research Institutions
- Mapping of Clinical Trial Product Services
- Recent Developments in Clinical Trials in the MENA Region
- Concluding Remarks from BCC
Chapter 8 Appendix
- Methodology
- Research Steps
- Sources
- Abbreviations
